Literature DB >> 6188530

Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies.

B S Wilson, G Ruberto, S Ferrone.   

Abstract

Sodium dodecyl sulfate polyacrylamide gel analysis of a high molecular weight (HMW) human melanoma associated antigen (MAA) defined by murine monoclonal antibodies revealed a number of distinct polypeptides ranging from 80,000 up to 280,000 daltons, in addition to an extremely heterogeneous group of components distributed over a wide range in apparent molecular weight (300,000-700,000 daltons). The 280,000 dalton and the larger heterogeneous molecular weight material are glycosylated since they are labeled with 3H-sugars. The HMW-MAA is readily solubilized in the absence of detergents and the entire series of polypeptides fractionates together in the void volume of a Sephadex G200 column. Peptide maps of the various polypeptides of the HMW-MAA, generated by Staphylococcus aureus V-8 protease, are essentially the same except that some of the proteolytic fragments derived from the lower molecular weight polypeptides (80,000 daltons) are present in greater amounts than are similar fragments derived from the larger molecular weight polypeptides; the latter finding suggests that the complexity in molecular weight of the MAA may reflect combinations of several base subunits. Proteolytic cleavage of the HMW-MAA generates a number of peptides ranging in molecular weight from 77,000 daltons to less than 12,000 daltons, which still react with monoclonal antibodies and can distinguish monoclonal antibodies specific for different antigenic determinants of this MAA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188530     DOI: 10.1007/bf00205360

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

2.  Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis.

Authors:  J P Segrest; R L Jackson; E P Andrews; V T Marchesi
Journal:  Biochem Biophys Res Commun       Date:  1971-07-16       Impact factor: 3.575

3.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

6.  Immunological detection of specific proteins in total cell extracts by fractionation in gels and transfer to diazophenylthioether paper.

Authors:  J Reiser; J Wardale
Journal:  Eur J Biochem       Date:  1981-03

7.  Peptide mapping of heterogeneous protein samples.

Authors:  C Bordier; A Crettol-Järvinen
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

8.  Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.

Authors:  M Herlyn; W H Clark; M J Mastrangelo; D P Guerry; D E Elder; D LaRossa; R Hamilton; E Bondi; R Tuthill; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

9.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

10.  Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin.

Authors:  J P Johnson; M Demmer-Dieckmann; T Meo; M R Hadam; G Riethmüller
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

View more
  13 in total

1.  Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

Authors:  Hong Zhou; Yuying Liu; Lawrence H Cheung; Sehoon Kim; Weihe Zhang; Khalid A Mohamedali; Preetha Anand; Walter N Hittelman; Bharat B Aggarwal; Michael G Rosenblum
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

3.  Characterisation of ocular melanoma with cutaneous melanoma antibodies.

Authors:  J Bomanji; A Garner; J Prasad; D M Albert; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

Review 4.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 5.  Exosome application in tumorigenesis: diagnosis and treatment of melanoma.

Authors:  Mohsen Karami Fath; Ali Azargoonjahromi; Nafiseh Jafari; Maryam Mehdi; Fatemeh Alavi; Mona Daraei; Niloufar Mohammadkhani; Anna-Lena Mueller; Aranka Brockmueller; Mehdi Shakibaei; Zahra Payandeh
Journal:  Med Oncol       Date:  2022-01-04       Impact factor: 3.064

Review 6.  The regulatory mechanisms of NG2/CSPG4 expression.

Authors:  Emmanuel Ampofo; Beate M Schmitt; Michael D Menger; Matthias W Laschke
Journal:  Cell Mol Biol Lett       Date:  2017-02-28       Impact factor: 5.787

Review 7.  CSPG4: a prototype oncoantigen for translational immunotherapy studies.

Authors:  Valeria Rolih; Giuseppina Barutello; Selina Iussich; Raffaella De Maria; Elena Quaglino; Paolo Buracco; Federica Cavallo; Federica Riccardo
Journal:  J Transl Med       Date:  2017-07-01       Impact factor: 5.531

8.  Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes.

Authors:  Beate M Schmitt; Anne S Boewe; Vivien Becker; Lisa Nalbach; Yuan Gu; Claudia Götz; Michael D Menger; Matthias W Laschke; Emmanuel Ampofo
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

9.  The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface.

Authors:  H J Garrigues; M W Lark; S Lara; I Hellström; K E Hellström; T N Wight
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

Review 10.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.